<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>Shockwave Medical, Inc News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/961</link>
		<description>Latest news from Shockwave Medical, Inc, as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Mon, 09 Mar 2026 23:18:13 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/newswire/customer-logos/961.jpg</url>
			<title>Shockwave Medical, Inc News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/961</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/961"/>
		<item xml:lang="en">
			<title>Shockwave Medical Completes Acquisition of Neovasc</title>
			<link>https://www.newsfilecorp.com/release/161912/Shockwave-Medical-Completes-Acquisition-of-Neovasc</link>
			<description>Santa Clara, California--(Newsfile Corp. - April 11, 2023) - Shockwave Medical, Inc. (NASDAQ: SWAV) ("Shockwave"), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the completion of its previously announced acquisition of Neovasc Inc. ("Neovasc").The Neovasc Reducer System (the "Reducer") is a first-of-its-kind technology to address refractory angina. Refractory angina is a chronic condition in which a patient...&lt;img src="https://api.newsfilecorp.com/newsinfo/161912/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 11 Apr 2023 08:18:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/161912</guid>
		</item>
		<item xml:lang="en">
			<title>Neovasc Shareholders Approve Acquisition by Shockwave Medical</title>
			<link>https://www.newsfilecorp.com/release/157454/Neovasc-Shareholders-Approve-Acquisition-by-Shockwave-Medical</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as defined below) have approved the previously-announced acquisition of all of the outstanding common shares of the Company (the "Shares") by Shockwave Medical, Inc. ("Shockwave") by way of a statutory plan of arrangement...&lt;img src="https://api.newsfilecorp.com/newsinfo/157454/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 06 Mar 2023 18:00:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/157454</guid>
		</item>
	</channel>
</rss>
